PrakashBhuyanMDPhD

Infectious Disease • Philadelphia, PA

Senior Vice President, Clinical Development

Join to view full profile

Dr. Bhuyan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhuyan's full profile

Already have an account?

Office
3900 Woodland Ave
University And Woodland Avenues
Philadelphia, PA 19104

Education & Training

University of Pennsylvania Health SystemFellowship, Infectious Disease, 2001 - 2003
Emory University School of MedicineResidency, Internal Medicine, 1998 - 2001
University of Texas Southwestern Medical SchoolClass of 1998

Certifications & Licensure

PA State Medical License 2001 - 2024
GA State Medical License 1999 - 2001

Clinical Trials

Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056) Start of enrollment: 2006 May 01
Completed
Phase 2
Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED) Start of enrollment: 2006 Sep 01
Completed
Phase 3
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057) Start of enrollment: 2006 Oct 06
Completed
Phase 3
Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED) Start of enrollment: 2006 Nov 01
Completed
Phase 3
A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) Start of enrollment: 2001 May 01
Completed
Phase 2
A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) Start of enrollment: 2001 May 01
Completed
Phase 2
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) Start of enrollment: 2017 Aug 31
Completed
Phase 2
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) Start of enrollment: 2017 Jun 28
Completed
Phase 3
VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2 Start of enrollment: 2018 May 15
Completed
Phase 2
VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions Start of enrollment: 2018 Sep 21
Active, not recruiting
Phase 2
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) Start of enrollment: 2019 Apr 09
Completed
Phase 3
Hepatitis B Vaccine in Seniors Start of enrollment: 2000 Mar 29
Completed
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

HPLC-MS/MS-based quantification of human monoclonal antibodies targeting SARS-CoV-2 in the presence of endogenous SARS-CoV-2 antibodies in human serum.
Alexander Schäfer, Peter Sagelsdorff, Björn Hock, Prakash Bhuyan, Norman Moullan
Analytical and Bioanalytical Chemistry. 2024-08-01
3 citations
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 M...
Norman Moullan, Josephat Asiago, Kathryn Stecco, Salah Hadi, Moetaz Albizem
Infectious Diseases and Therapy. 2024-01-01
42 citations
Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis.
Prakash Bhuyan, Jennie Medin, Hugo Gomes da Silva, Madhavi Yadavalli, Nirmal Kumar Shankar
Lancet. 2021-08-14

Press Mentions

INOVIO to Present at Upcoming Investor Conferences in MarchMarch 2nd, 2021
Inovio Pharmaceuticals Inc (NASDAQ: INO) Q1 2020 Earnings Call TranscriptMay 11th, 2020
INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-Associated Vulvar DysplasiaMarch 30th, 2020
Join now to see all

External Links

LinkedIN https://www.linkedin.com/in/prakash-bhuyan-a4584310/

PrakashBhuyanMDPhD

Dr. Bhuyan is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

External Links

Viewing the full profile is available to verified healthcare professionals only.